Nature Biotechnology

@naturebiotech · Twitter · 2023-12-08 21:14 UTC

@US_FDA approves two gene therapies for sickle cell disease: @bluebirdbio's #Lyfgenia and @VertexPharma & @CRISPRTX's #Casgevy, the first treatment in the US based on CRISPR gene editing technology #NBTNewsBeat https://www.reuters.com/business/healthcare-pharmaceuticals/us-approves-two-gene-therapies-sickle-cell-disease-2023-12-08/